Tirzepatide Shortage

FDA reconsiders removal of tirzepatide shortage

The Food and Drug Administration (FDA) announced on Friday that it would reconsider its decision to remove Eli Lilly’s tirzepatide from its shortage list. Tirzepatide

About NewsReports

NewsReports.com has been a haven for app geeks and business nerds. We provide content to a global audience via the internet, with a focus on finding trends before anyone else. The publication aims to provide highly reliable and highly accessible insights for all. 

A publication where apps, business, and technology come together to tell stories.

As seen in

techcrunch logo
venturebeat logo
business_of_apps